Comerica CMA underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 5 | 8 | 1 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 5 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $58.86, a high estimate of $75.00, and a low estimate of $50.00. Witnessing a positive shift, the current average has risen by 7.17% from the previous average price target of $54.92.
Exploring Analyst Ratings: An In-Depth Overview
The standing of Comerica among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Chiaverini | Wedbush | Raises | Outperform | $75.00 | $52.00 |
| Brandon King | Truist Securities | Raises | Hold | $66.00 | $53.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $58.00 | $58.00 |
| Peter Winter | DA Davidson | Maintains | Neutral | $55.00 | $55.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $69.00 | $50.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $61.00 | $50.00 |
| Manan Gosalia | Morgan Stanley | Lowers | Equal-Weight | $50.00 | $53.00 |
| Jon Arfstrom | RBC Capital | Lowers | Outperform | $56.00 | $58.00 |
| Scott Siefers | Piper Sandler | Raises | Neutral | $52.00 | $51.00 |
| Jason Goldberg | Barclays | Lowers | Underweight | $56.00 | $59.00 |
| Brandon King | Truist Securities | Lowers | Hold | $53.00 | $55.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Lowers | Market Perform | $56.00 | $58.00 |
| Michael Rose | Raymond James | Announces | Outperform | $60.00 | - |
| Steven Alexopoulos | JP Morgan | Lowers | Neutral | $57.00 | $62.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Comerica. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Comerica's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Comerica's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Comerica analyst ratings.
Delving into Comerica's Background
Comerica is a financial services company headquartered in Dallas. It is primarily focused on relationship-based commercial banking. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Comerica's Financial Performance
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Comerica's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -10.82%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Comerica's net margin is impressive, surpassing industry averages. With a net margin of 24.27%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Comerica's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.5%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Comerica's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.25%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Comerica's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.45.
Analyst Ratings: Simplified
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
